313 related articles for article (PubMed ID: 33918002)
21. BH3-only proapoptotic Bcl-2 family members Noxa and Puma mediate neural precursor cell death.
Akhtar RS; Geng Y; Klocke BJ; Latham CB; Villunger A; Michalak EM; Strasser A; Carroll SL; Roth KA
J Neurosci; 2006 Jul; 26(27):7257-64. PubMed ID: 16822983
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of E2F5 induces cell death via the TP53‑dependent pathway in breast cancer cells carrying wild‑type TP53.
Inagaki Y; Wu D; Fujiwara K; Ishizuka Y; Oguni A; Tokunaga T; Takayama T; Soma M; Fukuda N; Ozaki T; Masuda S
Oncol Rep; 2020 Nov; 44(5):2241-2252. PubMed ID: 33000282
[TBL] [Abstract][Full Text] [Related]
23. Role of Noxa in proliferation, apoptosis, and autophagy in human adenoid cystic carcinoma.
Liang L; Weng J; You Y; He Q; Fan Y; Liao G
J Oral Pathol Med; 2019 Jan; 48(1):52-59. PubMed ID: 30290043
[TBL] [Abstract][Full Text] [Related]
24. Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.
Ambrosini G; Sambol EB; Carvajal D; Vassilev LT; Singer S; Schwartz GK
Oncogene; 2007 May; 26(24):3473-81. PubMed ID: 17146434
[TBL] [Abstract][Full Text] [Related]
25. Crosstalk between Noxa, Bcl-2, and ceramide in mediating p53-dependent apoptosis in Molt-4 human T-cell leukemia.
Kobeissy H; Hage-Sleiman R; Dakdouk Z; Kozhaya L; Dbaibo G
Mol Cell Biochem; 2020 Dec; 475(1-2):215-226. PubMed ID: 32767230
[TBL] [Abstract][Full Text] [Related]
26. Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007.
Synnott NC; Bauer MR; Madden S; Murray A; Klinger R; O'Donovan N; O'Connor D; Gallagher WM; Crown J; Fersht AR; Duffy MJ
Cancer Lett; 2018 Feb; 414():99-106. PubMed ID: 29069577
[TBL] [Abstract][Full Text] [Related]
27. The PI3K/mTOR dual inhibitor NVP-BEZ235 stimulates mutant p53 degradation to exert anti-tumor effects on triple-negative breast cancer cells.
Cai J; Xia J; Zou J; Wang Q; Ma Q; Sun R; Liao H; Xu L; Wang D; Guo X
FEBS Open Bio; 2020 Apr; 10(4):535-545. PubMed ID: 32027103
[TBL] [Abstract][Full Text] [Related]
28. NOXA upregulation by the prohibitin-binding compound fluorizoline is transcriptionally regulated by integrated stress response-induced ATF3 and ATF4.
Núñez-Vázquez S; Sánchez-Vera I; Saura-Esteller J; Cosialls AM; Noisier AFM; Albericio F; Lavilla R; Pons G; Iglesias-Serret D; Gil J
FEBS J; 2021 Feb; 288(4):1271-1285. PubMed ID: 32648994
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of p53 protein is a marker of poor prognosis in Mexican women with breast cancer.
Dimas-González J; Maldonado-Lagunas V; Díaz-Chávez J; López-Arellano ME; Muñoz-Camacho J; Terán-Porcayo MA; Lagunas-Martínez A
Oncol Rep; 2017 May; 37(5):3026-3036. PubMed ID: 28393224
[TBL] [Abstract][Full Text] [Related]
30. HDM2 impairs Noxa transcription and affects apoptotic cell death in a p53/p73-dependent manner in neuroblastoma.
Shi Y; Takenobu H; Kurata K; Yamaguchi Y; Yanagisawa R; Ohira M; Koike K; Nakagawara A; Jiang LL; Kamijo T
Eur J Cancer; 2010 Aug; 46(12):2324-34. PubMed ID: 20591651
[TBL] [Abstract][Full Text] [Related]
31. COTI-2 reactivates mutant p53 and inhibits growth of triple-negative breast cancer cells.
Synnott NC; O'Connell D; Crown J; Duffy MJ
Breast Cancer Res Treat; 2020 Jan; 179(1):47-56. PubMed ID: 31538264
[TBL] [Abstract][Full Text] [Related]
32. Mutant p53 dictates the oncogenic activity of c-Abl in triple-negative breast cancers.
Morrison CD; Chang JC; Keri RA; Schiemann WP
Cell Death Dis; 2017 Jun; 8(6):e2899. PubMed ID: 28661474
[TBL] [Abstract][Full Text] [Related]
33. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract][Full Text] [Related]
34. AICAR induces apoptosis independently of AMPK and p53 through up-regulation of the BH3-only proteins BIM and NOXA in chronic lymphocytic leukemia cells.
Santidrián AF; González-Gironès DM; Iglesias-Serret D; Coll-Mulet L; Cosialls AM; de Frias M; Campàs C; González-Barca E; Alonso E; Labi V; Viollet B; Benito A; Pons G; Villunger A; Gil J
Blood; 2010 Oct; 116(16):3023-32. PubMed ID: 20664053
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress.
Jiang CC; Lucas K; Avery-Kiejda KA; Wade M; deBock CE; Thorne RF; Allen J; Hersey P; Zhang XD
Cancer Res; 2008 Aug; 68(16):6708-17. PubMed ID: 18701495
[TBL] [Abstract][Full Text] [Related]
36. E1A activates transcription of p73 and Noxa to induce apoptosis.
Flinterman M; Guelen L; Ezzati-Nik S; Killick R; Melino G; Tominaga K; Mymryk JS; Gäken J; Tavassoli M
J Biol Chem; 2005 Feb; 280(7):5945-59. PubMed ID: 15572378
[TBL] [Abstract][Full Text] [Related]
37. Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB.
Lallemand C; Blanchard B; Palmieri M; Lebon P; May E; Tovey MG
Oncogene; 2007 Jan; 26(3):328-38. PubMed ID: 16832344
[TBL] [Abstract][Full Text] [Related]
38. Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1.
Ray RM; Bhattacharya S; Johnson LR
Apoptosis; 2011 Jan; 16(1):35-44. PubMed ID: 20812030
[TBL] [Abstract][Full Text] [Related]
39. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
[TBL] [Abstract][Full Text] [Related]
40. Arenobufagin Induces Apoptotic Cell Death in Human Non-Small-Cell Lung Cancer Cells via the Noxa-Related Pathway.
Ma L; Zhu Y; Fang S; Long H; Liu X; Liu Z
Molecules; 2017 Sep; 22(9):. PubMed ID: 28892004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]